Argenx Se (ARGX) Non Operating Income (2017 - 2021)
Argenx Se (ARGX) posted Non Operating Income of -$325000.0 for Q2 2021, up 22.62% on a QoQ basis from -$420000.0 in Q1 2021, and down 127.36% year-over-year from $1.2 million in Q2 2020.
Argenx Se (ARGX) Non Operating Income (2017 - 2021) Analysis & Trends
Argenx Se's Non Operating Income history runs 5 years deep, the most recent figure standing at -$325000.0 for Q2 2021.
- Quarterly Non Operating Income fell 127.36% year-over-year to -$325000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $153924.2 (down 97.17% YoY) and the FY2021 annual result came in at -$944000.0, up 37.11% from the prior year.
- Non Operating Income was -$325000.0 for Q2 2021 at Argenx Se, up from -$420000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $4.0 million in Q3 2019 and bottomed at -$3.6 million in Q1 2020.
- A 5-year average of $617972.3 and a median of $449462.1 in 2020 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2018 — Non Operating Income surged 18588.22% — and 2021, when it tumbled 127.36%.
- Argenx Se's Non Operating Income stood at -$3196.2 in 2017, then jumped by 18588.22% to $590924.3 in 2018, then surged by 552.98% to $3.9 million in 2019, then slumped by 91.69% to $320726.0 in 2020, then slumped by 201.33% to -$325000.0 in 2021.
- Business Quant data shows ARGX's Non Operating Income at -$325000.0 in Q2 2021, -$420000.0 in Q1 2021, and $320726.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -46.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -325,000.00 |
| Mar 31, 2021 | -420,000.00 |
| Dec 31, 2020 | 320,725.97 |
| Sep 30, 2020 | 578,198.23 |
| Jun 30, 2020 | 1.19 Mn |
| Mar 31, 2020 | -3.59 Mn |
| Dec 31, 2019 | 3.86 Mn |
| Sep 30, 2019 | 3.98 Mn |
| Mar 31, 2018 | 590,924.27 |
| Mar 31, 2017 | -3,196.22 |